Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
| Autor: | Michael Gaziano, J.1,2,3 jmgaziano@partners.org, Brotons, Carlos4, Coppolecchia, Rosa5, Cricelli, Claudio6, Darius, Harald7, Gorelick, Philip B.8,9, Howard, George10, Pearson, Thomas A.11, Rothwell, Peter M.12, Ruilope, Luis Miguel13, Tendera, Michal14, Tognoni, Gianni15 |
|---|---|
| Zdroj: | Lancet. 9/22/2018, Vol. 392 Issue 10152, p1036-1046. 11p. |
| Databáze: | Business Source Ultimate |
| Externí odkaz: |
|